A partnership all about profits and less about patients

The Trans-Pacific Partnership (TPP) is no more than a corporate takeover for world economic domination. Thanks to Wikileaks, chapters of the TPP were published on the internet alerting us to the dangers of this secretive "trade agreement."

When the final text of the TPP was made public in the fall of 2015, the true nature of this nefarious deal was fully exposed. The TPP reaches into every aspect of society on a global scale.

One aspect that brings the TPP to a personal level is that of medicine. The TPP would allow pharmaceutical corporations to harm the health and welfare of large sectors of the world's population by allowing the extension of patents. This would delay generic and bio-similar drugs from being produced.

Bio-similars also known as " biologics," a class of drugs created from living cells, would have an additional five to eights years of patent protection. Through a process known as "evergreening," a minor change in a drug or a new use for an old drug would result in a patent extension, effectively patents could be held indefinitely. The longevity boom together with overburdened healthcare systems both in this county and around the globe propel the demand for generic drugs. The TPP is an attack on access to medicine by making drugs more expensive and less available.

For individuals whose lives depend on access to medicine, the TPP places a stranglehold on life-saving drugs provided by generics. Developing countries, who are signatories to the TPP, would be required to adhere to the same rules that apply to developed countries.


The TPP would allow these drug companies to skirt U.S., local, state and federal law. The Investor State Dispute Settlement provision of the TPP allows disputes to be settled in foreign tribunals who would have the authority to levy fines and enforce payments. The TPP allows Big Pharma to lock in monopoly profits.

Isabel Olivera-Morales, Boulder

TPP: Currency manipulation will undermine U.S. jobs

Several of the Trans Pacific Partnership (TPP) countries manipulate their currencies to make their goods cheaper and U.S. goods more expensive. If the TPP passes, this practice will contribute significantly to the U.S. trade deficit and the loss of American jobs — particularly in manufacturing.

The Obama administration failed to include enforceable disciplines against currency manipulation in the TPP, despite the facts that hundreds of Congressional democrats and republicans demanded it. Why? Because key nations refused to sign the TPP if it had any curbs on currency manipulation.

Instead, the Obama administration issued a Joint Resolution — not part of the TPP — that was supposed to take care of the problem. The Joint Resolution is not connected to the TPP, nor does it have an enforcement mechanism.

The Japanese government, a known currency manipulator, stated the Joint Resolution wouldn't affect its currency policy. Ford Motor Company concurred that Joint Resolution wouldn't affect TPP countries' currency manipulation.

This means that Japan and some other TPP countries will continue to manipulate their currencies, which will undermine American jobs and increase our trade deficit.

Congressman Jared Polis, of Boulder, will be voting on the TPP. Currency manipulation is just one of the many reasons for him to vote against it. Please call him and let him know what you think 303-484-9596. For more info on TPP go to www.citizen.org/TPP and to get involved locally carolynbninski@gmail.com

Carolyn Bninski, Rocky Mountain Peace and Justice Center, Boulder